Showing results (1261-1270 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1984
Five-day schedule of vinzolidine, an oral vinca alkaloid, in a variety of tumorsB J Takasugi, A B Robertone, S E Salmon, et al.Investigational New Drugs|January 1, 1984
Menogaril: a new anthracycline agent entering clinical trialsJ P McGovren, K G Nelson, M Lassus, et al.Investigational New Drugs|January 1, 1984
A phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-scheduleR A Joss, S Kaplan, A Goldhirsch, et al.Investigational New Drugs|January 1, 1983
The human tumor cloning assay in cancer drug development. A reviewP Agre, T E WilliamsInvestigational New Drugs|January 1, 1983
The clinical information system. Memorial Sloan-Kettering Cancer Center system for clinical oncologyM J SerberInvestigational New Drugs|January 1, 1984
Tiazofurin: a new antitumor agentP J O'Dwyer, D D Shoemaker, H N Jayaram, et al.Investigational New Drugs|January 1, 1984
Toxicity of ASTA Z 7557 (INN mafosfamide) to normal- and leukemic stem cells: implications for autologous bone marrow transplantationA Hagenbeek, A C MartensInvestigational New Drugs|October 20, 2022
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161Lakshmi Rajdev, Ju-Whei Lee, Steven K Libutti, et al.Investigational New Drugs|September 7, 2022
Carbidopa suppresses estrogen receptor-positive breast cancer via AhR-mediated proteasomal degradation of ERαZhiwei Chen, Xing Xia, Heyan Chen, et al.Investigational New Drugs|February 9, 2021
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapyFrancesco Pasqualetti, Alessandra Gonnelli, Paola Orlandi, et al.Pageof 372